Skip to content

Effect of intratracheal dexmedetomidine combined with lidocaine on postoperative sore throat: a randomised double-blinded controlled trial

Effect of intratracheal dexmedetomidine combined with lidocaine on postoperative sore throat: a randomised double-blinded controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074526
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-08-10
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid surgery

Interventions

Dexmedetomidine group (group D: dexmedetomidine 1µg/kg):After induction of general anesthesia for 3 min, the corresponding test drugs were diluted to 5ml, and then sprayed to the tracheal mucosa and g
Lidocaine group (group L: lidocaine 60mg):After induction of general anesthesia for 3 min, the corresponding test drugs were diluted to 5ml, and then sprayed to the tracheal mucosa and glottis by a di
Dexmedetomidine+lidocaine group (group DL: Dexmedetomidine 1µg/kg+lidocaine 60mg):After induction of general anesthesia for 3 min, the corresponding test drugs were diluted to 5ml, and then sprayed to
Saline group (group s):After induction of general anesthesia for 3 min, the corresponding test drugs were diluted to 5ml, and then sprayed to the tracheal mucosa and glottis by a disposable laryngeal

Sponsors

Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? American Society of Anesthesiology(ASA)I-II ? Mallampati grade I-II of airway. ? Age is 20-65 years old. ? Patients who plan to undergo thyroid surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: ?ASA=III; ? Body mass index (BMI) = 30kg/m-2; ? Severe cardiovascular, liver and renal dysfunction; Visual or hearing impairment; ? History of concealed airway or maxillofacial and neck surgery; ? Chronic use of opioids or sedatives; ? Chronic respiratory diseases; Recent respiratory tract infection; Chronic cough; ? The anesthesia time exceeds 4 hours; ? After the operation, the extubation time was more than 1 hour; ?Transfer to intensive care unit while still intubated.

Design outcomes

Primary

MeasureTime frame
Incidence and classification of postoperative sore throat;Incidence and classification of postoperative hoarseness;

Secondary

MeasureTime frame
Hemodynamic index;Duration of anesthesia, intubation and operation.;Fluid intake and output and The doses of all other medications used during surgery;Incidence of postoperative adverse reactions;

Countries

China

Contacts

Public ContactZhaoyang Xiao

Second Affiliated Hospital of Dalian Medical University

xiaozhaoy2006@hotmail.com+86 177 0987 3399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026